September 18, 2014 2:25 PM ET

Capital Markets

Company Overview of MedImmune Ventures, Inc.

Executive Profile

Isai Peimer

AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships
36--

Background

Mr. Isai Peimer serves as a Principal at MedImmune Ventures, Inc. Mr. Peimer joined MedImmune Ventures in August 2010. He served as a Venture Capitalist at Visium Asset Management. He served as an Investment Banker at J.P. Morgan and as a Specialty Pharmaceuticals Analyst at Alliance Bernstein. Prior to Wall Street, he was a Management Consultant and focused on corporate strategy for the pharmaceutical and biotech sectors. He began his career as a Scientist at Merck. ...

Corporate Headquarters

One MedImmune Way
Gaithersburg, Maryland 20878

United States

Phone: 301-398-3000
Fax: 301-398-8170

Board Members Memberships

Director
2011-Present
Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee

Education

MBA
Tuck School of Business at Dartmouth
BS
Emory University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MedImmune Ventures, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.